Expert Interview
Q2 #1: Digging into the Alzheimer's Landscape: Comparing Eisai/Biogen's Leqembi & Lilly's donanemab and novel therapies in development.
Ticker(s): BIIB, ESAIYInstitution: Mayo Clinic
- Clinical Neurologist at the Mayo Clinic with PhD in Neuroscience. Additionally certified in neuromuscular, autonomic and pain medicine.
- Manages 8 patients with Spinal Muscular Atrophy.
- Research focuses on autonomic disorders, specifically pure autonomic failure, autoimmune autonomic neuropathies, postural tachycardia syndrome and multiple system atrophy with a goal of characterizing and describing the natural history of these disorders, assessing quality of life for patients with these conditions, identifying predictors of good versus poor outcome and conducting therapeutic trials.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
